Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease

被引:59
作者
Al-Salmi, QA
Walter, JN
Colasurdo, GN
Sockrider, MM
Smith, EO
Takahashi, H
Fan, LL
机构
[1] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[2] Univ Texas, Houston Med Sch, Dept Pediat, Houston, TX USA
[3] Sapporo Med Univ, Sch Med, Dept Internal Med 3, Sapporo, Hokkaido, Japan
关键词
children; interstitial lung disease; KL-6; pneumo-protein; surfactant protein A; surfactant protein D;
D O I
10.1378/chest.127.1.403
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Objective: To determine if serum KL-6, surfactant protein A (SP-A), and surfactant protein D (SP-D) levels are elevated in pediatric interstitial lung disease (ILD) and associated with pulmonary function and disease se-verity score. Methods: Serum KL-6, SP-A, and SP-D levels were measured by enzyme-linked immunosorbent assay in 10 children with ILD and in 10 healthy volunteers. In the ILD group, FEV, percentage of predicted, FVC percentage of predicted, and ILD disease severity score were measured and correlated with serum KL-6, SP-A, and SP-D levels. Results: For the ILD and control groups, respectively, mean serum KL-6 was 4,523 U/mL and 206 U/mL (p = 0.0077), mean serum SP-A was 133 ng/mL and 21 ng/mL (p = 0.003), and mean serum SP-D was 304 ng/mL and 775 ng/mL (p = 0.004). There was an inverse relationship between SP-A and FVC (p = 0.05), and between SP-D and FEV, (p = 0.05). There was a direct relationship between SP-D and ILD score (p = 0.05). Conclusions: Serum KL-6, SP-D and SP-D levels are elevated in children with ILD. SP-A and SP-D levels appear to correlate with some measures of disease severity.
引用
收藏
页码:403 / 407
页数:5
相关论文
共 35 条
[1]
LUNG-FUNCTION TESTING - SELECTION OF REFERENCE VALUES AND INTERPRETATIVE STRATEGIES [J].
不详 .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (05) :1202-1218
[2]
Structure, biologic properties, and expression of surfactant protein D (SP-D) [J].
Crouch, EC .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1998, 1408 (2-3) :278-289
[4]
Factors influencing survival in children with chronic interstitial lung disease [J].
Fan, LL ;
Kozinetz, CA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (03) :939-942
[5]
Pediatric interstitial lung disease - Children are not small adults [J].
Fan, LL ;
Langston, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (11) :1466-1467
[6]
Alveolar epithelial type II cell: defender of the alveolus revisited [J].
Fehrenbach, H .
RESPIRATORY RESEARCH, 2001, 2 (01) :33-52
[7]
Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis [J].
Greene, KE ;
King, TE ;
Kuroki, Y ;
Bucher-Bartelson, B ;
Hunninghake, GW ;
Newman, LS ;
Nagae, H ;
Mason, RJ .
EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (03) :439-446
[8]
Surfactant protein A accumulating in the alveoli of patients with pulmonary alveolar proteinosis: Oligomeric structure and interaction with lipids [J].
Hattori, A ;
Kuroki, Y ;
Katoh, T ;
Takahashi, H ;
Shen, HQ ;
Suzuki, Y ;
Akino, T .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1996, 14 (06) :608-619
[9]
Lung epithelium-specific proteins - Characteristics and potential applications as markers [J].
Hermans, C ;
Bernard, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (02) :646-678
[10]
Pneumoproteinaemia: a new perspective in the assessment of lung disorders [J].
Hermans, C ;
Bernard, A .
EUROPEAN RESPIRATORY JOURNAL, 1998, 11 (04) :801-803